| Analysis | Metabolite Name | Measured Value | Units | Genotype | TREATMENT | TIME_POINT |
|---|---|---|---|---|---|---|
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.1169267 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.159645232 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.170109467 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.209885951 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.258887303 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.288065835 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.344013241 | Normalized AUC | SCAP KO | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.373130404 | Normalized AUC | WT | Freshly isolated (No treatment) | 0hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.409133326 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.557544295 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.613968303 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.628145523 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.661161213 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.687081611 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.70609522 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.921308203 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.944478682 | Normalized AUC | SCAP KO | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.951540508 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 0.980498238 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.015150793 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.041887496 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.101640402 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.116400017 | Normalized AUC | SCAP KO | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.127211068 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.146062778 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.149598435 | Normalized AUC | WT | anti-CD40 | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.176348509 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.215797668 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.314416573 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.356902323 | Normalized AUC | WT | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.360340062 | Normalized AUC | SCAP KO | LPS | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.453452724 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.469986084 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.632582699 | Normalized AUC | SCAP KO | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.819378425 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 1.858175388 | Normalized AUC | WT | anti-CD40 | 48hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 2.087419823 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 2.171832437 | Normalized AUC | WT | LPS | 24hr |
| Reversed phase/HILIC UNSPECIFIED ION MODE | 1-palmitoyl-GPE (16:0) | 2.529069164 | Normalized AUC | WT | LPS | 24hr |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|